GAMMA Investing’s Niagen Bioscience NAGE Stock Holding History

GAMMA Investing’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$5.89K	Buy	2,017 +1,659	+463%	+$5.29K	﹤0.01%	3581
2026 Q2	$1.14K	Sell	358 -107	-23%	-$434	﹤0.01%	3854
2026 Q1	$2.05K	Sell	465 -326	-41%	-$1.76K	﹤0.01%	3659
2025 Q4	$5.03K	Buy	791 +190	+32%	+$1.32K	﹤0.01%	3266
2025 Q3	$5.61K	Buy	601 +6	+1%	+$61	﹤0.01%	3133
2025 Q2	$8.57K	Buy	595 +55	+10%	+$543	﹤0.01%	2880
2025 Q1	$3.73K	Buy	540 +495	+1,100%	+$3.11K	﹤0.01%	3203
2024 Q4	$239	Buy	+45	New	+$246	﹤0.01%	3693

Other funds holding NAGE

MGI

Miller Global Investments Dallas, Texas $124M AUM 25.7% 1-Year Est. Return

ANBT

American National Bank & Trust Wichita Falls, Texas $1.09B AUM 26.59% 1-Year Est. Return

MAM

Marquette Asset Management Minneapolis, Minnesota $766M AUM 16.04% 1-Year Est. Return

GAMMA Investing's NAGE Position: Q3 2026 in Review

GAMMA Investing increased its Niagen Bioscience (NAGE) stake by 463% in Q3 2026, buying an estimated $5.29K and bringing the position to 2,017 shares worth $5.89K. The position accounts for ﹤0.01% of the portfolio, ranked #3581.

GAMMA Investing first reported a position in NAGE in Q4 2024 and has held it in 8 quarters since. The position peaked at $8.57K in Q2 2025. 4 funds tracked by Wall St. Rank hold NAGE as of Q3 2026.

GAMMA Investing held 2,017 shares of Niagen Bioscience worth $5.89K as of Q3 2026.
GAMMA Investing bought 1,659 Niagen Bioscience shares in Q3 2026, an estimated $5.29K.
Niagen Bioscience made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3581 holding.
GAMMA Investing first reported a position in Niagen Bioscience in Q4 2024 and has held it in 8 quarters since.
GAMMA Investing's Niagen Bioscience position peaked at $8.57K in Q2 2025.
4 funds tracked by Wall St. Rank held Niagen Bioscience as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.